30 Supported by research
Lean muscle mass is highly hydrated tissue, whereas fat mass contains very little water.
"So what we call muscle mass or lean mass is very hydrated tissue. Fat mass is actually not." (said at 0:02:18)
Body composition literature confirms that fat-free (lean) mass is a highly hydrated tissue compartment, with total water content consistently measured at approximately 70% to 73% across children, young adults, older adults, and athletes. In contrast, lipid/fat mass contains negligible water (and whole adipose tissue consists primarily of triglycerides with comparatively little water).
Muscle mass is inversely correlated with mortality.
"And muscle mass correlates, I mean, specifically with mortality, right? I mean, there's an inverse correlation.
[0:02:47] GUEST1: Absolutely." (said at 0:02:41)
Large systematic reviews and meta-analyses of prospective cohort studies consistently confirm that muscle mass (and fat-free mass) is inversely correlated with all-cause mortality in the general adult population. Individuals with lower muscle mass or muscle wasting consistently exhibit higher risks of all-cause and cause-specific mortality, with dose-response analyses demonstrating an inverse relationship between muscle mass markers and mortality risk.
- supports: Association of muscle wasting with mortality risk among adults: A systematic review and me… (Journal of cachexia, sarcopenia and muscle 2023) · cited 65x in the literature
"Muscle wasting was associated with higher mortality risks of all causes (RR = 1.36, 95% CI, 1.28 to 1.44, I 2 = 94.9%, 49 studies), cardiovascular disease (CVD) (RR = 1.29, 95% CI, 1.05 to 1.58, I 2 = 88.1%, 8 studies), cancer (RR = 1.14, 95% CI, 1.02 to 1.27, I 2 = 38.7%, 3 studies) and respiratory disease (RR = 1.36, 95% CI, 1.11 to 1.67, I 2 = 62.8%, 3 studies)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Low skeletal muscle mass index and all-cause mortality risk in adults: A systematic review… (PloS one 2023) · cited 36x in the literature
"Sixteen prospective studies were included in the meta-analysis of low SMI and the risk of all-cause mortality. A total of 11696 deaths were ascertained among 81358 participants during the 3 to 14.4 years follow-up. The pooled RR of all-cause mortality risk was 1.57 (95% CI, 1.25 to 1.96, P < 0.001) across the lowest to the normal muscle mass category." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Association Between Fat-Free Mass and Mortality: A Systematic Review and Meta-Analysis. (Journal of cachexia, sarcopenia and muscle 2026)
"Of 7741 screened records, 49 studies met the inclusion criteria (1 149 807 participants; 83 798 deaths). Low versus high fat-free mass was associated with higher all-cause mortality (RR: 1.42, 95% CI: 1.30-1.55)." (abstract, results, passage verified)
pubmedfull study (doi)
On a population level, humans lose muscle strength and power at a rate of approximately 1% to 3% per year, which is faster than the rate of muscle mass loss.
"and about a 1 to 3% drop in strength or power. So the muscle mass decline is actually slower than we lose strength" (said at 0:05:50)
Longitudinal cohort studies and systematic reviews demonstrate that muscle strength and power decline significantly faster with age than muscle mass. Large longitudinal studies (such as the Health ABC Study) indicate that older adults lose muscle strength at approximately 2% to 4% per year, which is roughly 2 to 5 times faster than the rate of muscle mass loss (which typically declines at around 0.5% to 1% per year).
- supports: The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging… (The journals of gerontology. Series A, Biological sciences and medical sciences 2006) · cited 3076x in the literature
"Annualized rates of leg strength decline (3.4% in white men, 4.1% in black men, 2.6% in white women, and 3.0% in black women) were about three times greater than the rates of loss of leg lean mass ( approximately 1% per year)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and s… (Frontiers in physiology 2012) · cited 1380x in the literature
"Longitudinal studies show that in people aged 75 years, muscle mass is lost at a rate of 0.64-0.70% per year in women and 0.80-00.98% per year in men. Strength is lost more rapidly. Longitudinal studies show that at age 75 years, strength is lost at a rate of 3-4% per year in men and 2.5-3% per year in women. Studies that assessed changes in mass and strength in the same sample report a loss of strength 2-5 times faster than loss of mass." (abstract, passage verified)
pubmedfull study (doi)
Both men and women can build bone mass up until approximately age 30.
"women in particular are told that we can we can build bone mass up until probably about 30. Men, it's about the same." (said at 0:06:52)
Published longitudinal cohort studies and endocrine consensus establish that peak bone mass (the maximum bone mineral accrual) is reached during the third decade of life (between the mid-20s and approximately age 30) in both males and females. Although the majority of bone mass is accrued during adolescence, consolidation and accumulation of bone mineral density and content continue into young adulthood until peak bone mass is achieved around this age window.
Studies in nonagenarians show that lifting weights can increase muscle strength and restore functional ability.
"But there are even studies in nonagenarians, you know, people in their 90s, lifting weights and they can get stronger. They're now gaining muscle not so much, but they get function back." (said at 0:07:50)
A landmark study by Fiatarone et al. (1990) evaluated 8 weeks of high-intensity resistance training in frail, institutionalized individuals aged 90 ± 1 years (up to 96 years old). The participants achieved substantial improvements in muscle strength (an average increase of 174%), modest increases in muscle cross-sectional area (9.0%), and notable gains in functional mobility, including a 48% improvement in tandem gait speed.
- supports: High-intensity strength training in nonagenarians. Effects on skeletal muscle. (JAMA 1990) · cited 658x in the literature
"Strength gains averaged 174% +/- 31% (mean +/- SEM) in the 9 subjects who completed training. Midthigh muscle area increased 9.0% +/- 4.5%. Mean tandem gait speed improved 48% after training. We conclude that high-resistance weight training leads to significant gains in muscle strength, size, and functional mobility among frail residents of nursing homes up to 96 years of age." (abstract, results and conclusions, passage verified)
pubmed
Population data show that meeting guidelines of 150 minutes of moderate-to-vigorous physical activity and two days of muscle-strengthening exercises per week is associated with an average of approximately four extra years of life.
"once you hit that sort of 150 minutes of moderate to vigorous, whichever, okay, that's the guidelines, and I think you maintain your strength and so make sure you do those two days of strengthening exercises a week. We get obviously we get on average, when you look at population data, about four extra years of life." (said at 0:10:18)
Large-scale pooled population studies support the claim that meeting standard physical activity guidelines is associated with approximately 3 to 4.5 additional years of life expectancy compared to inactivity. In a pooled analysis of six prospective cohort studies including 654,827 individuals (Moore et al., 2012), meeting the minimum recommended level of physical activity (equivalent to 150 minutes of brisk walking per week, or 7.5 to <15 MET-hours/week) was associated with a 3.4-year gain in life expectancy after age 40, increasing up to 4.5 years with higher activity levels. Similarly, prospective analyses in the UK Biobank (Chudasama et al., 2019) have shown that achieving recommended physical activity levels adds approximately 3.1 to 5.3 life years depending on baseline health status and activity measure.
- supports: Leisure time physical activity of moderate to vigorous intensity and mortality: a large po… (PLoS medicine 2012) · cited 704x in the literature
"A physical activity level of 0.1-3.74 MET-h/wk, equivalent to brisk walking for up to 75 min/wk, was associated with a gain of 1.8 (95% CI: 1.6-2.0) y in life expectancy relative to no leisure time activity (0 MET-h/wk). Higher levels of physical activity were associated with greater gains in life expectancy, with a gain of 4.5 (95% CI: 4.3-4.7) y at the highest level (22.5+ MET-h/wk, equivalent to brisk walking for 450+ min/wk)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Physical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study. (BMC medicine 2019) · cited 382x in the literature
"In participants with multimorbidity, at the age of 45 years, moderate and high LTPA were associated with an average of 3.12 (95% CI 2.53, 3.71) and 3.55 (2.34, 4.77) additional life years, respectively, compared to low LTPA; in participants without multimorbidity, corresponding figures were 1.95 (1.59, 2.31) and 1.85 (1.19, 2.50)... For objective PA, moderate and high levels were associated with 3.60 (- 0.60, 7.79) and 5.32 (- 0.47, 11.11) life years gained compared to low PA for those with multimorbidity and 3.88 (1.79, 6.00) and 4.51 (2.15, 6.88) life years gained in those without." (abstract, results, passage verified)
pubmedfull study (doi)
The Recommended Dietary Allowance (RDA) for daily protein intake for adults in the United States and Canada is 0.8 grams per kilogram of body weight.
"In the United States and Canada, it's it's about 0.8 grams of protein per kilogram body weight, correct?" (said at 0:11:53)
The Recommended Dietary Allowance (RDA) for daily protein intake established under the Dietary Reference Intakes (DRI) framework by the Institute of Medicine (now the National Academy of Medicine) for adults in the United States and Canada is 0.8 grams per kilogram of body weight per day (0.8 g/kg/day).
Alternative protein requirement assessment methods using stable isotopes indicate that human protein requirements to maintain balance are closer to 1.2 grams per kilogram of body weight per day.
"there are alternative approaches using stable isotopes that have consistently shown that people actually need—when I say need, to maintain the balance that we talk about—higher intakes. And so that's the 1.2." (said at 0:16:28)
Studies using stable isotope tracer methods, specifically the indicator amino acid oxidation (IAAO) technique (such as with L-[1-¹³C]phenylalanine), consistently indicate that the population-safe protein requirement (comparable to the Recommended Dietary Allowance) for adult humans is approximately 1.2 g/kg/day, with an estimated average requirement of ~0.93 g/kg/day. This is roughly 40–50% higher than traditional recommendations of 0.8 g/kg/day derived from historical nitrogen balance studies.
- supports: Reevaluation of the protein requirement in young men with the indicator amino acid oxidati… (The American journal of clinical nutrition 2007) · cited 173x in the literature
"The mean and population-safe (recommended dietary allowance; RDA) protein requirements were found to be 0.93 and 1.2 g kg(-1) d(-1), respectively. These requirements are comparable with those estimated by the application of a biphase linear regression model to the data from nitrogen balance studies (0.91 and 1.0 g kg(-1) d(-1), respectively). These requirements are 41% and 50% higher than the current recommendations for the estimated average requirement (EAR) of 0.66 g kg(-1) d(-1) and the RDA of 0.80 g kg(-1) d(-1)" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Evidence that protein requirements have been significantly underestimated. (Current opinion in clinical nutrition and metabolic care 2010) · cited 108x in the literature
"Considering the inherent problems associated with the nitrogen balance method, we developed an alternative method, the indicator amino acid oxidation technique, to determine protein requirements The mean and population-safe requirements in adult men were determined to be 0.93 and 1.2 g/kg/day and are 41 and 50%, respectively, higher than the current Dietary Reference Intakes recommendations." (abstract, results, passage verified)
pubmedfull study (doi)
Head-to-head primate studies investigating caloric restriction and lifespan extension have yielded conflicting results, with caloric restriction failing to extend lifespan in one of the two major study sites.
"when we compare primates head-to-head, so this is in caloric restriction, arguably the most robust model of survival extending lifespan, the data is actually conflicting. It's only been done, obviously, in two different locations, and so if you were a primate, you know, in one location, you did better than primates in the other, but the net result was it actually didn't extend lifespan." (said at 0:20:05)
The claim is supported. Only two major longitudinal studies have evaluated the effects of lifelong caloric restriction (CR) on lifespan in nonhuman primates (rhesus macaques). In 2009 and 2014, the University of Wisconsin (WNPRC) study reported that CR significantly extended survival and reduced mortality, whereas the 2012 report from the National Institute on Aging (NIA) study found that CR did not extend overall survival. Later collaborative analyses identified that differences in study protocols, baseline diet composition, and age of onset accounted for these conflicting findings.
Spending six months to a year in space results in the equivalent of 10 to 15 years of skeletal and muscle aging.
"And we know that, you know, six months or a year spending up at the space station is about 10 to 15 years of skeletal and muscle aging, and it's tough to get back." (said at 0:24:10)
The claim is supported. Long-duration spaceflight (4 to 12 months) induces accelerated bone and muscle loss that mimics multiple years to decades of natural terrestrial aging. In a study evaluating astronauts after 4 to 6 months on the International Space Station, proximal femoral bone strength and mineral density decreased at rates of approximately 1% to 2.6% per month in weight-bearing bones, resulting in cumulative losses equivalent to 10 to 15 or more years of age-related bone decline on Earth. Furthermore, studies tracking astronauts post-flight demonstrate that structural bone loss and trabecular microarchitectural deficits can persist for years and are difficult to completely recover.
Beyond approximately 1.6 grams of protein per kilogram of body weight per day, additional protein intake does not further support muscle protein synthesis or lean mass accrual.
"I think 1.6 grams per kilo—and I know people like to talk in pounds, so you know, it's something around sort of 0.6 to 0.7 grams per pound—and those levels, after that, you can digest and eat lots more protein, your body just can't use it." (said at 0:28:10)
A systematic review and meta-analysis of 49 randomized controlled trials involving 1,863 participants undergoing resistance exercise training found that dietary protein intake significantly augmented gains in fat-free mass and muscle strength up to a plateau of 1.62 g/kg/day (95% CI: 1.03 to 2.20 g/kg/day). Beyond approximately 1.6 g/kg/day, higher protein intakes did not further increase resistance training-induced gains in lean body mass.
Different animal classes excrete excess nitrogenous waste from protein metabolism in distinct forms: fish excrete ammonia, birds excrete uric acid, and mammals excrete urea.
"Every species has evolved a way of getting rid of extra protein: fish, it's ammonia; birds, it's uric acid; mammals, it's urea." (said at 0:13:48)
Comparative animal physiology establishes that aquatic animals (such as fish) primarily excrete nitrogenous waste as ammonia (ammonotely), terrestrial mammals convert nitrogen waste to urea (ureotely), and birds and reptiles convert it to uric acid (uricotely) (PMID: 7699310, PMID: 12042332). While environmental shifts or dietary conditions can alter secondary excretion pathways in specific species (such as nectarivorous birds under high water throughput, PMID: 12042332), the general rule for primary nitrogenous waste excretion across these major animal groups matches the speaker's statement.
Humans exhibit lower insulin sensitivity later in the evening compared to earlier in the day.
"you're not as insulin sensitive later in the evening" (said at 0:25:28)
Human physiological studies consistently show a diurnal variation in glucose tolerance and insulin sensitivity, with insulin sensitivity peaking in the morning and significantly declining by the evening, independent of fasting duration or prior exercise.
For younger individuals performing resistance training, consuming 1.6 grams of protein per kilogram of body weight per day optimizes lean body mass gains.
"if you're younger and you're resistance training, so you're lifting weights, you want to get a bit bigger, a bit stronger, 1.6 grams of protein per kilo per day was the, the type of intake that you need to consume." (said at 0:31:41)
A landmark systematic review and meta-analysis of 49 randomized controlled trials encompassing 1,863 participants performing resistance exercise training evaluated the effect of total protein intake on gains in fat-free mass and strength. Using breakpoint regression analysis, the authors demonstrated that gains in fat-free mass plateaued at a total daily protein intake of approximately 1.62 g/kg/day (95% CI: 1.03–2.20 g/kg/day), with no further benefits observed at higher intakes. The analysis also found that the efficacy of protein supplementation on fat-free mass gains was greater in younger adults compared to older adults.
Caloric deficits act as a catabolic stimulus on skeletal muscle.
"Again, you're sort of tipping the scales in the favor of the breakdown side of things. That's just, you know, calorie deficits are catabolic stimuli, and it's catabolic for muscle too." (said at 0:33:43)
Caloric deficits induce a catabolic environment in skeletal muscle, shifting net muscle protein balance into a negative state. Human randomized trials show that dietary energy restriction reduces muscle protein synthesis (MPS) without necessarily altering muscle protein breakdown (MPB), which leads to net muscle protein loss unless mitigated by sufficient protein intake and resistance training.
Muscle protein is made up of 20 amino acids, of which 9 are essential and 3 are branched-chain amino acids.
"if that's muscle protein, it's made up of 20 different types of bricks. Those are the 20 amino acids that we have, nine of which are essential, we need to get them in our diet. And in particular, they're a group of what are called branched-chain amino acids that are three of the nine" (said at 0:39:18)
Standard human biochemistry establishes that body proteins, including muscle proteins, are composed of 20 standard proteinogenic amino acids. Of these, 9 are nutritionally essential (cannot be synthesized de novo in sufficient quantities by humans and must be obtained from the diet), and 3 of these 9 essential amino acids are branched-chain amino acids (leucine, isoleucine, and valine).
Leucine triggers muscle protein synthesis in a dose-dependent manner up to a plateau point.
"the most potent, if you like, of the three branched chains is an amino acid called leucine. And the way I like to explain it to people is that it's kind of like the the brick that when it arrives, it turns the process on... So once you have sufficient leucine there, you can turn the switch up as bright as it can go. Once you put more leucine there, you can't go any higher." (said at 0:39:40)
The speaker accurately describes the 'leucine trigger' and 'leucine threshold' models of muscle protein synthesis (MPS). Leucine acts as a primary signaling molecule activating the mammalian target of rapamycin complex 1 (mTORC1) pathway. In acute nutritional studies, stimulating MPS exhibits a dose-dependent response to leucine up to a saturating threshold (typically ~2 to 3 g per dose), beyond which additional leucine yields no further acute increase in synthesis rates. Systematic reviews confirm this trigger/threshold dynamic for isolated protein ingestion and acute postprandial MPS regulation, particularly in older adults, although long-term phenotypic adaptations also depend heavily on total daily protein intake.
Aging reduces sensitivity to leucine, requiring higher amounts of leucine, branched-chain amino acids, or essential amino acids to stimulate muscle protein synthesis.
"For older people, for reasons that we're beginning to unravel now, I think what happens is now the sensitivity of that dimmer switch—so the leucine comes and you sort of get this response, and a younger person, you might get that. And so we need more leucine or more branched chains or more essential amino acids, which translates into more—you need more protein to trigger the whole turning the protein synthetic process on." (said at 0:40:29)
The speaker's statement accurately reflects clinical and metabolic trial evidence regarding age-related anabolic resistance. Controlled metabolic studies utilizing stable isotope tracers and muscle biopsies demonstrate that older adults exhibit an attenuated muscle protein synthesis (MPS) response to standard doses or proportions of essential amino acids/leucine compared to younger adults, and that higher doses of leucine or overall protein are necessary to overcome this threshold and stimulate MPS.
Plant-derived proteins contain anti-nutritional factors like fiber and phytates that can inhibit protein breakdown enzymes and reduce amino acid bioavailability.
"Plant-derived proteins have anti-nutritional—fiber is one, phytates, lots of other things that can inhibit protein breakdown enzymes. And you know, you say that's a big deal, it's going to lower the quality, you're not going to get as many amino, essential amino acids." (said at 0:41:40)
Plant-derived protein sources naturally contain antinutritional factors (ANFs)—including protease/trypsin inhibitors, phytates (phytic acid), tannins, and insoluble dietary fiber—that can inhibit digestive enzymes, complex with proteins, and reduce protein digestibility and essential amino acid bioavailability compared to animal protein sources. Conventional and novel food processing techniques (e.g., cooking, soaking, fermentation, and extraction) are widely used specifically to reduce or deactivate these factors.
- supports: Effects of antinutritional factors on protein digestibility and amino acid availability in… (Journal of AOAC International 2005) · cited 470x in the literature
"Food and feed products may contain a number of antinutritional factors that may adversely affect protein digestibility and amino acid availability. Antinutritional factors may occur naturally, such as glucosinolates in mustard and rapeseed protein products, trypsin inhibitors and hemagglutinins in legumes, tannins in legumes and cereals, phytates in cereals and oilseeds, and gossypol in cottonseed protein products." (abstract, passage verified)
pubmed - supports: Food processing for the improvement of plant proteins digestibility. (Critical reviews in food science and nutrition 2020) · cited 437x in the literature
"The digestibility specifies the protein quantity absorbed by an organism relative to the consumed amount and depends on the protein structure, previous processing, and the presence of compounds limiting the digestion. The latter are so-called antinutritional factors (ANF), exemplified by phytates, tannins, trypsin inhibitors, and lectins. Animal proteins are known to have better digestibility than plant proteins due to the presence of ANF in plants." (abstract, passage verified)
pubmedfull study (doi)
Preparation methods such as cooking, sprouting, and fermentation liberate plant proteins and reduce anti-nutritional effects, increasing bioavailability.
"a lot of the prep methods of plant proteins like beans and legumes, you cook them, and cooking actually liberates a lot of the proteins that makes them more bioavailable and so reduces the anti-nutritional effects. So sprouting, cooking, fermentation, all kinds of things that are commonly done with plant-based proteins, beans, legumes, I think are making the two proteins much more close in quality inside us than we once thought." (said at 0:42:53)
Extensive food science and nutritional literature confirms that traditional preparation and processing methods—including thermal cooking, germination (sprouting), and fermentation—degrade or inactivate antinutritional factors (such as trypsin inhibitors, lectins, phytic acid, and tannins) and alter protein structure, thereby enhancing protein digestibility and nutrient bioavailability in legumes and pulses.
- supports: Nutritional and Functional Attributes of Legumes: A Review of Processing Methods and Their… (Journal of food science 2026)
"However, naturally occurring antinutritional factors (ANFs), like phytic acid, tannins, lectins, and trypsin inhibitors, impede the utilization of their nutritional value by hindering mineral absorption and protein breakdown... Germination improves protein digestibility and micronutrient bioavailability, whereas soaking elevates soluble dietary fiber by as much as 33%... Moreover, thermal treatments effectively neutralize heat-sensitive ANFs..." (abstract, passage verified)
pubmedfull study (doi) - supports: Biotechnological Modulation of Legumes via Fermentation: Impacts on Nutrient Bioaccessibil… (Foods (Basel, Switzerland) 2026) · cited 2x in the literature
"Microbial organic acid production and the mechanical penetration of fungal hyphae promote a 90-100% degradation and elimination of phytates and condensed tannins, eliminating non-digestible galacto-oligosaccharides and inactivating trypsin inhibitors. These mechanisms optimize phytate-to-mineral molar ratios, doubling the bioaccessibility of iron, zinc, and calcium in the digestive aqueous phases..." (abstract, passage verified)
pubmedfull study (doi)
The optimal per-meal leucine dose to stimulate muscle protein synthesis is approximately 3 to 4 grams for older adults and 2 to 3 grams for younger adults.
"the per-meal leucine dose is probably somewhere in the range of sort of three to four grams for an older person, probably two to three for younger, and that's just because the younger person is really sensitive to the effects." (said at 0:50:25)
The claim accurately summarizes the established 'leucine trigger' concept in protein metabolism. Younger adults are more sensitive to amino acid stimulation and generally saturate muscle protein synthesis (MPS) with approximately 2 to 3 g of leucine per meal (roughly 20–25 g of high-quality protein). In contrast, older adults exhibit age-related anabolic resistance and require a higher leucine threshold of roughly 3 to 4 g per meal (roughly 35–40 g of protein) to achieve a robust postprandial MPS response.
Local limb immobilization in younger adults induces muscle atrophy and creates an anabolic resistance response similar to that seen in older adults.
"But we can make a younger person, when we put a brace on their leg and we get local atrophy, their—atrophied muscle looks like an older person's response. So the disuse response, we think, is sort of—it's almost a model of premature aging in terms of your muscle, anyway." (said at 0:50:40)
The speaker's claim is supported. Experimental models of limb immobilization and physical disuse in healthy young adults induce rapid skeletal muscle atrophy, declines in muscle protein synthesis, and anabolic resistance to nutritional and exercise stimuli. In muscle physiology research, disuse paradigms (such as knee bracing, casts, or step reduction) are widely recognized and utilized as human models for studying the phenotypic and metabolic characteristics of premature aging and sarcopenia.
- supports: Muscle Disuse as a Pivotal Problem in Sarcopenia-related Muscle Loss and Dysfunction. (The Journal of frailty & aging 2016) · cited 131x in the literature
"reports have documented that 2-3 weeks of reduced daily steps may induce: negative changes in body composition, reductions in muscle strength and quality, anabolic resistance, and decrements in glycemic control in older adults." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Plasticity and function of human skeletal muscle in relation to disuse and rehabilitation:… (Danish medical journal 2017) · cited 14x in the literature
"Importantly, within the first 4 days of immobility the ob-served atrophy responses did not seem affected by age, as manifested by comparable reductions in myofibre area in young and old individuals." (abstract, results, passage verified)
pubmed - supports: Reduced physical activity in young and older adults: metabolic and musculoskeletal implica… (Therapeutic advances in endocrinology and metabolism 2019) · cited 278x in the literature
"In untrained individuals, even a short-term reduction in physical activity has a significant impact on skeletal muscle protein and carbohydrate metabolism, causing anabolic resistance and peripheral insulin resistance, respectively." (abstract, results, passage verified)
pubmedfull study (doi)
Abrupt step reduction induces anabolic resistance in older individuals.
"We have done some studies where we've used step reduction, like abrupt step reduction, as a model of sort of abrupt sedentarism, where we can make older people much more anabolically resistant as a result of that." (said at 0:51:15)
Human metabolic studies demonstrate that short-term, abrupt step reduction (such as reducing daily steps by ~75–80% for 14 days) induces anabolic resistance in older adults, characterized by a significant blunting of postprandial myofibrillar protein synthesis and accelerated loss of leg fat-free mass.
Resistance exercise increases the rate of muscle protein breakdown as well as muscle protein synthesis.
"And when you're lifting or you're doing any type of resistance and/or strength training, you are also causing muscle protein breakdown. GUEST1: Yeah, absolutely, yeah... physical exercise—and particularly some forms, but weightlifting is a really potent one—turns up the rate at which we're pulling bricks out of the wall. You're creating damage, you're creating a stress on the muscle. Successful adaptation to stress is that you're able to repair that damage and replace those damaged proteins, and that's the synthesis side of things." (said at 0:56:33)
Human metabolic tracer studies consistently show that resistance exercise stimulates overall muscle protein turnover by simultaneously increasing both muscle protein synthesis (MPS) and muscle protein breakdown (MPB). In the fasted state following resistance exercise, both synthesis and degradation rates are elevated, leaving net muscle protein balance negative until exogenous amino acids/dietary protein are consumed to exceed the breakdown rate and yield net accretion.
Adding supplemental leucine to a suboptimal or low-protein dose stimulates muscle protein synthesis to a level comparable to a higher-protein dose.
"if you take even a small protein dose and you add a little bit of extra leucine, you can make it look as if it's a bigger protein dose." (said at 0:49:58)
Randomized trials demonstrate that supplementing a suboptimal, low dose of protein (e.g., 6.25 g of whey protein) with additional leucine stimulates acute rates of myofibrillar protein synthesis (MPS) to levels comparable to a standard higher-protein dose (e.g., 25 g of whey protein). For example, Churchward-Venne et al. (2014) showed that 6.25 g of whey supplemented to 5.0 g of total leucine stimulated 0–4.5 h postprandial MPS equivalently to 25 g of whey protein in healthy young men.
Aging impairs insulin-mediated capillary recruitment and vasodilation in skeletal muscle without necessarily causing overt glycemic insulin resistance.
"when you turn on insulin, you usually open up blood vessels to allow flow to happen. And what we think happens with aging is that response becomes just a little bit less sensitive. You're not insulin resistant from the perspective of blood sugar, but from a protein perspective, we think that opening up local capillaries and allowing good blood flow in older people just isn't quite as sensitive." (said at 0:51:58)
Human physiological studies demonstrate that aging is associated with impaired insulin-mediated muscle capillary recruitment and microvascular vasodilation. In healthy, non-diabetic older adults, feeding- or insulin-induced microvascular perfusion is blunted despite intact or near-normal glycemic regulation, which impairs postprandial amino acid delivery and contributes to muscle anabolic resistance. Restoring microvascular perfusion pharmacologically has been shown to rescue insulin-stimulated muscle protein synthesis in older adults.
- supports: Pharmacological vasodilation improves insulin-stimulated muscle protein anabolism but not … (Diabetes 2010) · cited 147x in the literature
"Skeletal muscle protein metabolism is resistant to the anabolic action of insulin in healthy, nondiabetic older adults. This defect is associated with impaired insulin-induced vasodilation and mTORC1 signaling." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Development of a new Sonovue™ contrast-enhanced ultrasound approach reveals temporal and a… (Physiological reports 2013) · cited 86x in the literature
"Younger men (N = 6) exhibited biphasic vascular responses to feeding with early increases in MBV (+36%, P < 0.008 45 min post feed) reflecting capillary recruitment... All circulatory responses were absent in old men (N = 7)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Increased muscle blood supply and transendothelial nutrient and insulin transport induced … (The Journal of physiology 2016) · cited 80x in the literature
"This review concludes that a sedentary lifestyle, obesity and ageing impair the vasodilator response of the muscle microvasculature to insulin, exercise and VEGF-A and reduce microvascular density." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Branched-chain amino acid (BCAA) supplements provide minimal additional benefit for muscle protein synthesis beyond the specific action of leucine.
"I think the message is fairly clear now that they're largely—I won't say useless, but from useful to useless, they're a lot closer to the useless end. But it's only the leucine out of those three amino acids that's the important branched-chain amino acid, so they work because of the leucine." (said at 0:47:25)
The speaker's assertion is supported by metabolic and clinical evidence. Leucine is the specific branched-chain amino acid that acts as a key trigger for muscle protein synthesis (MPS) signaling via the mTORC1 pathway. However, isolated BCAA supplements (which supply only leucine, isoleucine, and valine without the full complement of all nine essential amino acids) cannot sustain elevated protein synthesis because all essential amino acids are required as substrates. Consequently, isolated BCAA supplements provide negligible practical benefit for building muscle compared to whole dietary protein sources or complete essential amino acid mixtures.
Global physical activity guidelines commonly recommend performing muscle-strengthening activities at least two days per week.
"Most of the guidelines you look around the world, there's a recommendation for two times a week of strengthening activities." (said at 0:53:30)
Major international and national physical activity guidelines, including those published by the World Health Organization (WHO) and the U.S. Department of Health and Human Services, explicitly recommend that adults perform muscle-strengthening activities involving all major muscle groups on at least 2 days per week, in addition to aerobic exercise.
Post-exercise restorative and recovery processes in adults are driven primarily by macronutrients, and endogenous IGF-1 does not serve as a stimulatory or inhibitory driver of muscle repair.
"Most of the rest, the restorative process and the recovery process, is driven almost exclusively by macronutrients. And so IGF-1, I'm like, yeah, it needs to be there, but it's not a stimulatory or an inhibitory hormone for repair or recovery." (said at 1:01:38)
Human experimental studies demonstrate that transient post-exercise elevations in systemic endogenous insulin-like growth factor 1 (IGF-1) do not drive or enhance post-exercise muscle protein synthesis (MPS) or muscle hypertrophy. Instead, post-exercise restorative and anabolic processes are primarily driven by local intramuscular signaling mechanosensing and macronutrient availability (such as dietary protein and amino acid ingestion).
- supports: Resistance exercise-induced increases in putative anabolic hormones do not enhance muscle … (The Journal of physiology 2009) · cited 288x in the literature
"We conclude that the transient increases in endogenous purportedly anabolic hormones do not enhance fed-state anabolic signalling or MPS following resistance exercise. Local mechanisms are likely to be of predominant importance for the post-exercise increase in MPS." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Human exercise-mediated skeletal muscle hypertrophy is an intrinsic process. (The international journal of biochemistry & cell biology 2010) · cited 114x in the literature
"However, while these hormones are clearly anabolic during childhood and puberty, or when given at supraphysiological exogenous doses, the transient post-exercise elevations in hormone concentration are of little consequence to the either the acute protein synthetic response or to a hypertrophic phenotype after resistance training." (abstract, passage verified)
pubmedfull study (doi) - supports: Muscular and systemic correlates of resistance training-induced muscle hypertrophy. (PloS one 2013) · cited 185x in the literature
"There was no relationship between the magnitude of the pre- or post-training exercise-induced changes in free testosterone, GH, or IGF-1 concentration and muscle fiber hypertrophy... Acute increases, in p70S6K phosphorylation and changes in muscle AR protein content correlated with muscle hypertrophy implicating intramuscular rather than systemic processes in mediating hypertrophy." (abstract, results, passage verified)
pubmedfull study (doi)
Creatine monohydrate is the most extensively studied chemical form of creatine supplement.
"The monohydrate form is the one to to aim for. Don't be fooled by creatine insert your favorite derivative. Um, monohydrate is is the one that's been most studied, and and so probably the one you want to go for, for sure." (said at 1:46:46)
Creatine monohydrate is universally recognized in systematic reviews and scientific literature as the most extensively researched and validated form of creatine supplementation. Reviews comparing creatine monohydrate to alternative chemical formulations (such as creatine ethyl ester, magnesium-creatine chelate, creatine nitrate, pyruvate, or citrate) show that the vast majority of efficacy and safety data in humans are based on creatine monohydrate. Furthermore, alternative derivative forms have not demonstrated superior bioavailability, efficacy, or safety over monohydrate.
- supports: Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. (Amino acids 2011) · cited 180x in the literature
"The form of creatine that has been most extensively studied and commonly used in dietary supplements is creatine monohydrate (CM). ... However, there is little to no evidence that any of the newer forms of creatine are more effective and/or safer than CM whether ingested alone and/or in combination with other nutrients." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Efficacy of Alternative Forms of Creatine Supplementation on Improving Performance and Bod… (Journal of strength and conditioning research 2022) · cited 19x in the literature
"Due to the paucity of studies on alternative forms of creatine as well as high prices on the market of these alternative forms, CrM remains as the most extensively studied form of creatine that shows efficacy, safety, and lowest cost to consumer." (abstract, conclusions, passage verified)
pubmedfull study (doi)
25 No source found (not proven false)
On a population level, aging humans lose approximately 1% of muscle mass per year.
"And usually what we say on a population level, it's about a 1% loss of muscle mass per year" (said at 0:05:43)
No published record matching the claim that aging humans lose approximately 1% of muscle mass per year on a population level was located in the evaluated abstracts; this does not prove the claim false. While progressive age-related loss of skeletal muscle mass and function (sarcopenia) is well-documented in clinical consensus literature, specific population-wide rate estimates vary depending on the age cohort, sex, measurement modality, and physical activity levels.
Free-form leucine is readily absorbed by the body.
"No, you absorb it in free form. In fact, it's really readily absorbed." (said at 0:48:57)
No published record matching the claim that free-form leucine is readily absorbed by the body was located; this does not prove the claim false.
Leucine activates muscle protein synthesis primarily through mTOR signaling.
"Leucine goes through mTOR. Its dysregulation is involved in all kinds of processes, including cancer and lots of other things. So it has a really centrally important role in integrating all of those anabolic signals." (said at 1:03:10)
Extensive mechanistic and human clinical evidence demonstrates that leucine stimulates skeletal muscle protein synthesis primarily via activation of the mechanistic target of rapamycin (mTOR / mTORC1) signaling pathway. Leucine acts as a key nutrient sensor and signaling trigger for translation initiation and protein synthesis, and mTOR is widely recognized as a central integrator of anabolic signals whose dysregulation is implicated in metabolic dysfunction and oncogenesis. [citation dropped: PMID did not verify]
The search did find related studies, but none that directly tests this claim:
In observational studies adjusting for unhealthy lifestyle confounders (e.g., obesity, smoking, physical inactivity, excess alcohol), individuals consuming animal protein have similar all-cause mortality to individuals consuming plant protein.
"However, when you start to look at the largest observational studies that have been done, those studies that have looked for any like unhealthy lifestyle factors and confounding factors have found that, oh, actually, people that have no unhealthy lifestyle factors—so they're not obese, not sedentary, not smoking, not excessively drinking alcohol—they have a similar all-cause mortality as a plant-eating person." (said at 1:06:05)
The claim accurately reflects findings from major prospective cohort analyses (such as Song et al., 2016, examining 131,342 participants in the Nurses' Health Study and Health Professionals Follow-up Study). In that study, after adjusting for major lifestyle and dietary risk factors, high plant protein intake was associated with lower all-cause and cardiovascular mortality, but these protective associations were confined to participants with at least one unhealthy lifestyle factor (e.g., smoking, heavy alcohol intake, overweight/obesity, or physical inactivity) and were not evident among individuals without any of these risk factors. Because these findings originate from observational prospective cohorts subject to residual confounding and self-reported diet measures, the grade of certainty is low. [citation dropped: PMID did not verify]
A meta-analysis by Brandon Roberts showed that men and women achieve the same relative muscle growth gains relative to baseline in response to resistance training.
"and this is a meta-analysis now, a guy named Brandon Roberts did this one, and you resistance train them relative to what they started with, everybody goes up the same amount. Women get the same amount of muscle growth as men do, but they had less muscle to start with" (said at 1:10:50)
A 2020 systematic review and meta-analysis led by Brandon M. Roberts evaluated sex differences in response to resistance training among young to middle-aged adults. Analyzing 12 hypertrophy outcomes across 10 studies, the authors found no statistically significant difference in relative muscle growth between males and females (effect size = 0.07 ± 0.06; p = 0.31; I² = 0%), supporting the claim that relative muscle hypertrophy gains are similar between sexes. [citation dropped: PMID did not verify]
Bone composition is approximately 40% protein by weight, structured as a layer of collagenous protein.
"Your bone is actually about 40% by composition protein. It's not just a stick of chalk. There's a layer of collagenous protein around it." (said at 1:16:40)
No published record matching the specific claim that bone is approximately 40% protein by weight structured as an outer layer of collagenous protein was located; this does not prove the claim false.
Individuals with Laron syndrome (growth hormone receptor deficiency) do not develop cancer.
"and this is where you've had Dr. Longo on the show before, he shows in certain populations of dwarves, for example, who have a particular type of dwarfism and lack of growth hormone receptor, they're actually—they don't get cancer." (said at 1:18:45)
Longitudinal cohort studies by Dr. Valter Longo, Dr. Jaime Guevara-Aguirre, and colleagues demonstrated that individuals with growth hormone receptor deficiency (Laron syndrome) have a dramatically reduced incidence of cancer compared to unaffected relatives, but cancer is not completely absent. In a 22-year follow-up study of the Ecuadorian cohort, one nonlethal malignancy was documented among GHR-deficient individuals (compared to a 17% cancer prevalence in unaffected controls). An international survey of 230 patients with Laron syndrome similarly observed zero reported cancer cases, indicating near-complete protection, though an absolute claim that they 'do not get cancer' slightly overstates the findings. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
Higher levels of leisure-time physical activity are associated with a reduced risk in 13 of the 26 most common types of cancer.
"13 of the 26 most common types of cancer are lower in people who have higher levels of leisure-time physical activity." (said at 1:25:05)
A landmark pooled analysis of 12 prospective cohorts comprising 1.44 million adults (Moore et al., 2016) investigated the association between leisure-time physical activity and 26 types of cancer. Comparing high versus low levels of leisure-time physical activity (90th vs. 10th percentile), physical activity was statistically significantly associated with a reduced risk of 13 specific cancers: esophageal adenocarcinoma, liver, lung, kidney, gastric cardia, endometrial, myeloid leukemia, myeloma, colon, head and neck, rectal, bladder, and breast cancer. [citation dropped: PMID did not verify]
Two or three consecutive sauna sessions separated by 5 to 10 minutes of cooling can produce up to a 16-fold transient elevation in growth hormone.
"you could do like two or three back-to-back sauna sessions separated by, you know, 5 or 10 minutes of cooling, and you could get up to like a 16-fold transient elevation in growth hormone." (said at 1:26:40)
Heat exposure in a sauna robustly stimulates the hypothalamic-pituitary axis to cause acute, transient elevations in circulating growth hormone (GH), typically mediated by growth hormone-releasing hormone (GHRH). While standard single sauna sessions typically produce 2- to 5-fold elevations in plasma GH (e.g., 140% to 250% increases), intensive protocols involving multiple prolonged or repeated heat sessions separated by cooling intervals can elicit transient GH surges reaching up to approximately 16-fold over baseline in young, healthy subjects. However, this endocrine response is brief (plasma concentrations return to baseline within 1 to 2 hours), is markedly blunted or absent in older adults, and reflects a transient physiological stress response rather than sustained elevation of baseline growth hormone. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
In adults, exogenous growth hormone acts primarily as a fat-mobilizing hormone and does not significantly promote muscle mass accretion.
"in the case of growth hormone, it's actually a fat-mobilizing hormone. That's one of its great side effects if you're taking exogenous growth hormone; you notice you get leaner. It probably doesn't do much for your muscle." (said at 1:27:45)
Multiple systematic reviews and meta-analyses of randomized controlled trials confirm that exogenous growth hormone (GH) acts primarily as a potent lipolytic (fat-mobilizing) agent, reducing body fat mass and increasing circulating free fatty acids and glycerol. Although GH administration increases measured lean body mass (or fat-free mass), studies demonstrate that this change is driven primarily by extracellular fluid retention and connective tissue synthesis rather than myofibrillar muscle protein synthesis, contractile muscle hypertrophy, or gains in muscle strength. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
Androgen deprivation therapy in men with prostate cancer induces a hypogonadal state accompanied by muscle mass loss.
"if you take men and they have a diagnosis of prostate cancer, they're often put on androgen deprivation therapy. So they're taken from a normal testosterone state to a hypogonadal state, and yeah, they lose muscle mass." (said at 0:10:19)
The claim is well supported. Androgen deprivation therapy (ADT) for prostate cancer suppresses circulating testosterone to castrate (hypogonadal) levels. A well-established adverse effect of this severe testosterone suppression is a significant decline in skeletal muscle and lean body mass, which often leads to sarcopenia and increases in fat mass unless counteracted with targeted resistance exercise. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
Muscle androgen receptor content increases in response to resistance training.
"You have shown that androgen receptor content increases with resistance training and is correlated with muscle protein synthesis.
GUEST1: Yeah." (said at 0:19:28)
The claim is partially accurate but requires qualification. In young men completing chronic resistance training, overall skeletal muscle androgen receptor (AR) protein content on average does not significantly increase, but the individual *change* in muscle AR content is positively correlated with the degree of muscle fiber hypertrophy and p70S6K phosphorylation (a key marker of muscle protein synthesis signalling) across individuals (Mitchell et al., 2013, PMID: 24130904). Furthermore, acute responses of AR protein content to a single bout of resistance exercise are dynamic—often transiently decreasing immediately post-exercise (PMID: 15748830, PMID: 19683543) before restoring or increasing depending on protein feeding and endogenous hormone levels (PMID: 16826026, PMID: 19429451). Thus, while AR content changes correlate with muscle growth adaptations and protein synthesis mechanisms, training itself does not uniformly increase mean baseline AR protein content in human skeletal muscle. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
The search did find related studies, but none that directly tests this claim:
Exercise training can increase the size of the hippocampus in the human brain.
"15, 20 years ago if you said, "Well, you can change the size of your hippocampus and your brain with exercise," they'd have been like, "Right."" (said at 0:25:47)
Randomized controlled trials and meta-analyses demonstrate that exercise training can modify hippocampal volume in humans. In a landmark randomized controlled trial of 120 older adults, 1 year of aerobic exercise training increased anterior hippocampal volume by approximately 2%, reversing age-related volume loss. Subsequent systematic reviews and meta-analyses of controlled exercise trials have confirmed significant positive effects on hippocampal volume compared to non-exercising controls, primarily reflecting a combination of volume enlargement and preservation against expected age-related atrophy. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
Exercise produces improvements in depressive and anxiety symptoms of a magnitude comparable to pharmaceutical interventions.
"You get, you know, improvements in mood, you get improvements in depressive symptoms, anxiety, and everything, almost of the magnitude similar to people taking pharmaceutical interventions for those things." (said at 0:25:55)
Systematic reviews and network meta-analyses of randomized controlled trials demonstrate that exercise and physical activity produce reductions in depressive and anxiety symptoms with effect sizes comparable to antidepressant medications and standard psychological interventions, particularly in non-severe depression. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
Heat shock proteins act as molecular chaperones that prevent protein misfolding and help mitigate muscle atrophy.
"what we understand now is that they chaperone, or they act as essentially little proteins that bind to other proteins to prevent them from being what we call misfolded... And we're beginning to see more and more that you can alleviate muscle atrophy" (said at 0:28:50)
Heat shock proteins (HSPs) are a well-characterized family of molecular chaperones whose primary function is assisting proper protein folding and preventing the aggregation of misfolded or damaged proteins. Extensive preclinical and mechanistic research demonstrates that HSPs (such as Hsp70, Hsp90, Hsp25, and αB-crystallin) protect skeletal muscle proteostasis, suppress key atrogenic pathways (including the ubiquitin-proteasome and autophagy-lysosome systems), and help mitigate muscle wasting during conditions of disuse, denervation, and aging. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
A sham-controlled trial found that heat stress produces an antidepressant effect in patients with major depressive disorder.
"there's been a sham-controlled trial looking at the effects of heat stress on major depressive disorder. There was a sham control, and basically it had an antidepressant effect." (said at 1:31:53)
A double-blind, randomized, sham-controlled clinical trial (Janssen et al., 2016) evaluated the antidepressant effects of whole-body hyperthermia (WBH) in 30 patients diagnosed with major depressive disorder. Compared to the sham condition (which matched all aspects of the procedure except intense heat), a single session of active whole-body hyperthermia produced statistically significant and sustained reductions in Hamilton Depression Rating Scale scores across a 6-week follow-up period. [citation dropped: PMID did not verify]
The heat shock protein response can be locally induced by heating a single limb rather than requiring whole-body hyperthermia.
"it seems that the heat shock response is something you can locally induce, right? It doesn't have to be a sauna, so you can heat one leg and not the other leg, for an example." (said at 1:35:28)
No published record matching the claim that the heat shock response can be locally induced by heating a single limb rather than requiring whole-body hyperthermia was located; this does not prove the claim false.
Local tissue heating opens capillaries and increases tissue perfusion.
"And again, the cardiovascular effects to do with that and opening up capillaries and so more perfusion of them, I mean, there's all kinds of things that are suggestive that there could be something going on there, yeah, for sure." (said at 1:35:48)
Local tissue heating directly induces thermal hyperemia, increasing tissue perfusion and causing microvascular capillary recruitment (opening of capillaries). Human physiological studies show that local hyperthermia produces substantial, localized increases in microvascular blood flow and tissue oxygenation, while direct microvascular imaging confirms that heating increases the number of open, perfused capillaries and the time precapillary sphincters remain open. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
Vitamin D receptor activation regulates roughly 5% of the protein-encoding human genome.
"it is a steroid hormone that is doing similar things like testosterone in the sense where it is a binding receptor going into the cell nucleus and regulating, changing all kinds of genes. Like 5% of the protein-encoding human genome." (said at 1:37:01)
Genome-wide mapping studies (ChIP-seq and transcriptomic analyses) indicate that ligand-activated vitamin D receptor (VDR) binds between 1,000 and over 10,000 genomic sites depending on cell type, directly or indirectly regulating the expression of roughly several hundred to over 1,000 to 2,000 protein-coding genes across various human tissues (approximately 3% to 5% of the estimated ~20,000 human protein-coding genes). [citation dropped: PMID did not verify] [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
High-dose omega-3 supplementation attenuated disuse muscle atrophy and accelerated muscle recovery following two weeks of single-leg immobilization in young women.
"We supplemented one group with very high-dose omega-3 fatty acids and we supplemented the other group with sort of a corn oil placebo, and then we braced one of their legs for our local disuse atrophy model for two weeks. And the women on the omega-3 supplement saw a really mild disuse atrophy response, and then returned to normal much quicker than the other group who saw a much greater atrophic response and didn't get back to normal after two weeks of we call it passive remobilization." (said at 1:38:32)
The speaker accurately describes the results of a randomized controlled trial (McGlory et al., 2019) in 20 healthy young women. Participants received either 5 g/day of omega-3 fatty acids or a control oil starting 4 weeks prior to 2 weeks of unilateral leg immobilization, followed by 2 weeks of recovery. The omega-3 group showed significantly attenuated loss of muscle volume during immobilization (8% reduction vs. 14% in the control group) and fully recovered their muscle volume after 2 weeks of returning to normal activity, whereas the control group remained significantly below baseline. [citation dropped: PMID did not verify]
Dr. Mark Tarnopolsky prescribes 4 to 5 grams of creatine monohydrate daily to patients with neuromuscular diseases, such as mitochondrial myopathies and muscular dystrophies, to treat muscle weakness.
"A good friend of mine, Mark Tarnopolsky, neuromuscular physician, has all of his neuromuscular patients on it. So I think that that's a fairly robust endorsement of what it can do for people with compromised muscle function, and he recommends that these people just start with a dose of about, you know, four to five grams of creatine a day." (said at 1:45:46)
Dr. Mark Tarnopolsky, a neuromuscular specialist and researcher, has extensively evaluated and recommended creatine monohydrate supplementation (typically at maintenance doses of approximately 3 to 5 grams daily, or ~0.1 g/kg/day) for patients with neuromuscular and neurometabolic conditions, including muscular dystrophies and mitochondrial cytopathies. Clinical trials led by Tarnopolsky and Cochrane systematic reviews co-authored by him demonstrate that creatine monohydrate supplementation improves muscle strength and high-intensity performance in muscular dystrophies and mitochondrial cytopathies. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
Creatine monohydrate supplementation improves cognitive performance and brain function.
"Now the brain and the cognitive side of things is is, you know, the evidence is growing in that area, too." (said at 1:44:10)
The speaker's statement that evidence is growing regarding creatine's effects on brain and cognitive function is supported by recent systematic reviews and meta-analyses. A 2024 systematic review and meta-analysis of 16 randomized controlled trials (RCTs) found that creatine monohydrate supplementation produced modest, statistically significant improvements in memory (SMD = 0.31), attention time, and processing speed, though overall cognitive function and executive function showed no significant differences. A 2023 meta-analysis of RCTs in healthy individuals similarly demonstrated a significant positive effect of creatine supplementation on memory performance (SMD = 0.29), with pronounced benefits observed in older adults. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
Over 40 years of research on creatine supplementation has shown no causal link to kidney damage or increased cancer incidence, with adverse events being rare.
"There was a lot of talk about it's damaging your kidneys, it's doing, you know, this you shouldn't, you know, it's a it's a guanidino compound, etc., etc. Um, we've got 40 years' worth of data with people on the supplement now and and we're not seeing some sort of rife wave of of people who used it getting various forms of cancer, etc., etc. All the data reviewing it from a safety standpoint has given it two thumbs up. The adverse events are are rare" (said at 1:44:10)
Extensive clinical trial data and multiple systematic reviews and meta-analyses show that creatine monohydrate supplementation does not cause kidney damage in healthy individuals, does not increase cancer incidence, and is generally safe with rare adverse events. While creatine intake leads to minor increases in circulating serum creatinine, true measures of renal function and glomerular filtration rate (such as Cr-EDTA clearance, serum urea, and proteinuria) remain unaffected, reflecting increased metabolic turnover of creatine rather than renal injury. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify] [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
In the pathology of sarcopenia, proteostasis is disrupted in Type II muscle fibers.
"There was this degradation or proteostasis—the basically proteostasis was messed up in Type II—was it Type II muscle fibers? GUEST1: Yep." (said at 1:32:24)
The statement is supported. In the pathophysiology of sarcopenia (age-related loss of muscle mass and function), impaired proteostasis—arising from dysregulation of protein synthesis, the ubiquitin-proteasome system, and the autophagy-lysosome pathway—is a primary driver of muscle atrophy, with type II (fast-twitch) muscle fibers undergoing preferential and progressive degeneration and atrophy. [citation dropped: PMID did not verify] [citation dropped: PMID did not verify]
Specialized pro-resolving mediators derived from omega-3 fatty acids include resolvins, protectins, and maresins.
"there's like the specialized pro-resolving mediators, there's the resolvins, the protectins, the maresins. It isn't just prostaglandins, it's not just this one pathway." (said at 1:39:03)
Specialized pro-resolving mediators (SPMs) are an established family of bioactive lipid autacoids derived from polyunsaturated fatty acids, particularly the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The major SPM families derived from omega-3s include resolvins (E-series and D-series), protectins (such as protectin D1/neuroprotectin D1), and maresins, which actively orchestrate the resolution of inflammation and tissue repair. [citation dropped: PMID did not verify]
The search did find related studies, but none that directly tests this claim:
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.